Thu. Nov. 19, 2020 1:00 PM – 2:00 PM


From accelerating clinical trials and gaining regulatory approval to expanding access and understanding market needs, this webinar will cover the basics of what makes real-world data regulatory and research grade and how it can transform your R&D and market access programs for autoimmune and other chronic conditions, including RA, SLE, MS, and HF.

Join Dr. Richard Gliklich, CEO of OM1, as he explores:

·Data quality and getting to regulatory-grade results
·How new technologies can collect and process data for RWE applications
·RWD utility across research and development
·Case examples in rheumatology, multiple sclerosis, heart failure and more

**Please be advised this webinar is intended for pharmaceutical and medical device companies. Due to the proprietary nature of the content, all registration approval is at the discretion of OM1. Vendors and consultants will not be permitted to attend at this time.